INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Gross margin 2016–2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) gross margin by fiscal year — reported gross profit divided by reported revenue.
50.9%FY2025 · since FY2016: 64.8% → 50.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 50.9% | -3.9 pp |
| FY2024 | 54.8% | -2.6 pp |
| FY2023 | 57.4% | -4.9 pp |
| FY2022 | 62.3% | +1.0 pp |
| FY2021 | 61.2% | -0.8 pp |
| FY2020 | 62.0% | -0.8 pp |
| FY2019 | 62.8% | +1.6 pp |
| FY2018 | 61.2% | -2.2 pp |
| FY2017 | 63.3% | -1.5 pp |
| FY2016 | 64.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IART financial trends
IART RevenueIART Net incomeIART Net marginIART Gross profitIART Operating incomeIART Operating marginIART Operating cash flowIART Free cash flowIART Capital expendituresIART Return on equityIART Stock buybacksIART Dividends paidIART Total assetsIART Total liabilitiesIART Shareholders’ equityIART overview →